These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. DOXIL superior for KS. Posit Aware; 1995; ():7. PubMed ID: 11362576 [TBL] [Abstract][Full Text] [Related]
6. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services. AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227 [TBL] [Abstract][Full Text] [Related]
7. Misprint of dosage interval for liposomal doxorubicin hydrochloride. Subach RA; Ruble J Am J Health Syst Pharm; 1996 Jul; 53(14):1727. PubMed ID: 8827244 [No Abstract] [Full Text] [Related]
8. DOXIL approved for KS. James JS AIDS Treat News; 1995 Dec; (no 236):6. PubMed ID: 11363051 [TBL] [Abstract][Full Text] [Related]
9. Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy. Gabizon AA Cancer Invest; 2001; 19(4):424-36. PubMed ID: 11405181 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. Northfelt DW; Dezube BJ; Thommes JA; Levine R; Von Roenn JH; Dosik GM; Rios A; Krown SE; DuMond C; Mamelok RD J Clin Oncol; 1997 Feb; 15(2):653-9. PubMed ID: 9053490 [TBL] [Abstract][Full Text] [Related]
15. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Coukell AJ; Spencer CM Drugs; 1997 Mar; 53(3):520-38. PubMed ID: 9074848 [TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity after liposomal anthracyclines. Young AM; Dhillon T; Bower M Lancet Oncol; 2004 Nov; 5(11):654. PubMed ID: 15522651 [No Abstract] [Full Text] [Related]
17. Doxil offers hope to KS sufferers. Prescott LM J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097 [TBL] [Abstract][Full Text] [Related]